Efficacy and Safety of ATG-Fresenius as an Induction Agent in Living-Donor Kidney Transplantation


YILMAZ M. , SEZER T. Ö. , GÜNAY E., SOLAK I., ÇELTİK A. , HOSCOSKUN C., ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.49, ss.481-485, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background. Induction therapy is mostly recommended for deceased-donor transplantation, whereas it has some controversies in live-donor transplantation. In this study, we described the outcomes of live-donor renal transplant recipients who received ATG-Fresenius (ATG-F) induction.